Attovia Therapeutics ATTO
Valuation
Multiples measured against the stock's own five-year history
Near the top of its 5-year range · 94th percentile, 5-year average -11.3x
Near the top of its 5-year range · 96th percentile, 5-year average -5.3x
#2784 of 5329 stocks by PB (1 = cheapest)
Around its usual level · 56th percentile, 5-year average 478.6x
#5058 of 5155 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 1.74 | – | -5.27 | 96% (pricier than usual) | #2784 of 5329 (1 = cheapest) |
| PE | -8.76 | -7.14 | -11.32 | 94% (pricier than usual) | – |
| PS | 480.30 | – | 478.64 | 56% (pricier than usual) | #5058 of 5155 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on ATTO.
Sign in to join the discussion.